Rezolute, Inc. (RZLT)
3.85
-0.23
(-5.64%)
USD |
NASDAQ |
Jun 09, 15:54
Rezolute SG&A Expense (Quarterly) : 5.954M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Inovio Pharmaceuticals, Inc. | 7.880M |
| SELLAS Life Sciences Group, Inc. | 4.123M |
| Marker Therapeutics, Inc. | 1.230M |
| ADMA Biologics, Inc. | 27.80M |